Leukemia inhibitory factor-induced stat3 signaling suppresses fibroblast growth factor 1-induced Erk1/2 activation to inhibit the downstream differentiation in mouse embryonic stem cells

Stem Cells and Development

Volumn 22, Issue 8, 2013, Pages 1190-1197

  Liu, Jen Wei ^a,b   Hsu, Yi Chao ^a   Kao, Chien Yu ^a,c   Su, Hong Lin ^b   Chiu, Ing Ming ^a,b,c  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 1; LEUKEMIA INHIBITORY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; DOWN REGULATION; EMBRYO; EMBRYONIC STEM CELL; IMMUNOPRECIPITATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLAST GROWTH FACTOR 1; LEUKEMIA INHIBITORY FACTOR; MEMBRANE PROTEINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PLURIPOTENT STEM CELLS; PROTEIN BINDING; PYRIDINES; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TYRPHOSTINS;

EID: 84876138469     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0229     Document Type: Article

References (40)

1. Aubert J, MP Stavridis, S Tweedie, M O'Reilly, K Vierlinger, M Li, P Ghazal, T Pratt, JO Mason, D Roy and A Smith. (2003). Screening for mammalian neural genes via fluorescence-activated cell sorter purification of neural precursors from Sox1-gfp knock-in mice. Proc Natl Acad Sci U S A 100 (Suppl. 1):11836-11841.
2. Matsuda T, T Nakamura, K Nakao, T Arai, M Katsuki, T Heike and T Yokota. (1999). STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. Embo J 18:4261-4269.
3. Lee JT, Jr. and JA McCubrey. (2002). The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia. Leukemia 16:486-507.
4. Mehta VB, L Connors, HC Wang and IM Chiu. (1998). Fibroblast variants nonresponsive to fibroblast growth factor 1 are defective in its nuclear translocation. J Biol Chem 273:4197-4205.
5. Niwa H, K Ogawa, D Shimosato and K Adachi. (2009). A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 460:118-122.
6. Hamazaki T, SM Kehoe, T Nakano and N Terada. (2006). The Grb2/Mek pathway represses Nanog in murine embryonic stem cells. Mol Cell Biol 26:7539-7549.
7. Hacohen N, S Kramer, D Sutherland, Y Hiromi and MA Krasnow. (1998). Sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 92:253-263.
8. Impagnatiello MA, S Weitzer, G Gannon, A Compagni, M Cotten and G Christofori. (2001). Mammalian sprouty-1 and - 2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells. J Cell Biol 152: 1087-1098.
9. Yusoff P, DH Lao, SH Ong, ES Wong, J Lim, TL Lo, HF Leong, CW Fong and GR Guy. (2002). Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf. J Biol Chem 277:3195-3201.
10. Ozaki K, S Miyazaki, S Tanimura and M Kohno. (2005). Efficient suppression of FGF-2-induced ERK activation by the cooperative interaction among mammalian Sprouty isoforms. J Cell Sci 118:5861-5871.
11. TsangMand IBDawid. (2004).Promotionand attenuationofFGF signaling through the Ras-MAPK pathway. Sci STKE 2004:pe17.
12. Boeuf H, C Hauss, FD Graeve, N Baran and C Kedinger. (1997). Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells. J Cell Biol 138:1207-1217.
13. Niwa H, T Burdon, I Chambers and A Smith. (1998). Selfrenewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev 12:2048-2060.
14. Raz R, CK Lee, LA Cannizzaro, P d'Eustachio and DE Levy. (1999). Essential role of STAT3 for embryonic stem cell pluripotency. Proc Natl Acad Sci U S A 96:2846-2851.
15. ErnstMand BJ Jenkins. (2004). Acquiring signalling specificity from the cytokine receptor gp130. Trends Genet 20:23-32.
16. Cartwright P, C McLean, A Sheppard, D Rivett, K Jones and S Dalton. (2005). LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132:885-896.
17. Boyle K and L Robb. (2008). The role of SOCS3 in modulating leukaemia inhibitory factor signalling during murine placental development. J Reprod Immunol 77:1-6.
18. Forrai A, K Boyle, AH Hart, L Hartley, S Rakar, TA Willson, KM Simpson, AW Roberts, WS Alexander, AK Voss and L Robb. (2006). Absence of suppressor of cytokine signalling 3 reduces self-renewal and promotes differentiation in murine embryonic stem cells. Stem Cells 24:604-614.
19. Boyle K, JG Zhang, SE Nicholson, E Trounson, JJ Babon, EJ McManus, NA Nicola and L Robb. (2009). Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation. Cell Signal 21:394-404.
20. Ying QL, J Wray, J Nichols, L Batlle-Morera, B Doble, J Woodgett, P Cohen and A Smith. (2008). The ground state of embryonic stem cell self-renewal. Nature 453:519-523.
21. Patrie K, MJ Botelho, SK Ray, VB Mehta and IM Chiu. (1997). Amphibian FGF-1 is structurally and functionally similar to but antigenically distinguishable from its mammalian counterpart. Growth Factors 14:39-57.
22. Patrie KM, MJ Botelho, K Franklin and IM Chiu. (1999). Sitedirected mutagenesis and molecular modeling identify a crucial amino acid in specifying the heparin affinity of FGF-1. Biochemistry 38:9264-9272.
23. Wen Z and JE Darnell, Jr. (1997). Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3. Nucleic Acids Res 25:2062-2067.
24. Horvath CM, Z Wenand JE Darnell, Jr. (1995).ASTAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev 9:984-994.
25. Zhong Z, Z Wen and JE Darnell, Jr. (1994). Stat3 and Stat4: Members of the family of signal transducers and activators of transcription. Proc Natl Acad Sci U S A 91:4806-4810.
26. Okita K and S Yamanaka. (2006). Intracellular signaling pathways regulating pluripotency of embryonic stem cells. Curr Stem Cell Res Ther 1:103-111.
27. Ferrajoli A, S Faderl, Q Van, P Koch, D Harris, Z Liu, I Hazan-Halevy, Y Wang, HM Kantarjian, W Priebe and Z Estrov. (2007). WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells. Cancer Res 67:11291-11299.
28. Verstovsek S, T Manshouri, A Quintas-Cardama, D Harris, J Cortes, FJ Giles, H Kantarjian,WPriebe and Z Estrov. (2008). WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutation. Clin Cancer Res 14:788-796.
29. Nesaretnam K and P Meganathan. (2011). Tocotrienols: Inflammation and cancer. Ann N Y Acad Sci 1229:18-22.
30. Kannappan R, VR Yadav and BB Aggarwal. (2010). gamma-Tocotrienol but not gamma-tocopherol blocks STAT3 cell signaling pathway through induction of protein-tyrosine phosphatase SHP-1 and sensitizes tumor cells to chemotherapeutic agents. J Biol Chem 285:33520-33528.
31. Benekli M, Z Xia, KA Donohue, LA Ford, LA Pixley, MR Baer, H Baumann and M Wetzler. (2002). Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival. Blood 99:252-257.
32. Hoshino R, Y Chatani, T Yamori, T Tsuruo, H Oka, O Yoshida, Y Shimada, S Ari-i, H Wada, J Fujimoto and M Kohno. (1999). Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene 18:813-822.
33. Downward J. (2003). Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3:11-22.
34. Kisseleva T, S Bhattacharya, J Braunstein and CW Schindler. (2002). Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285:1-24.
35. Fukuda S and T Taga. (2005). Cell fate determination regulated by a transcriptional signal network in the developing mouse brain. Anat Sci Int 80:12-18.
36. Chen YC, DC Lee, TY Tsai, CY Hsiao, JW Liu, CY Kao, HK Lin, HC Chen, TJ Palathinkal, et al. (2010). Induction and regulation of differentiation in neural stem cells on ultrananocrystalline diamond films. Biomaterials 31:5575-5587.
37. Hsu YC, DC Lee, SL Chen,WCLiao, JW Lin,WTChiu and IM Chiu. (2009). Brain-specific 1B promoter of FGF1 gene facilitates the isolation of neural stem/progenitor cells with selfrenewal and multipotent capacities. Dev Dyn 238:302-314.
38. Lee DC, YC Hsu, YF Chung, CY Hsiao, SL Chen, MS Chen, HK Lin and IM Chiu. (2009). Isolation of neural stem/progenitor cells by using EGF/FGF1 and FGF1B promoterdriven green fluorescence from embryonic and adult mouse brains. Mol Cell Neurosci 41:348-363.
39. Lin WF, CJ Chen, YJ Chang, SL Chen, IM Chiu and L Chen. (2009). SH2B1beta enhances fibroblast growth factor 1 (FGF1)-induced neurite outgrowth through MEK-ERK1/2-STAT3-Egr1 pathway. Cell Signal 21:1060-1072.
40. Chen CW, CS Liu, IM Chiu, SC Shen, HC Pan, KH Lee, SZ Lin and HL Su. (2010). The signals of FGFs on the neurogenesis of embryonic stem cells. J Biomed Sci 17:33.